UPDATED Jun 30, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ADOC | €7.80 | 2.2% | 97.0% | €114.9m | €9.70 | PS19x | E104.5% | n/a | Pharmaceuticals & Biotech | ||
OSE | €5.46 | -9.8% | 64.2% | €118.8m | €7.15 | PS53.3x | E79.3% | n/a | Pharmaceuticals & Biotech | ||
ALOKW | €18.20 | -3.9% | -31.1% | €150.4m | €30.30 | PE19.9x | E30.8% | n/a | Capital Goods | ||
VU | €130.30 | -1.5% | 41.5% | €2.1b | €195.20 | PE26x | E25.2% | 0.2% | Tech | ||
FDE | €28.60 | -4.7% | -41.3% | €149.6m | €61.33 | PE19x | E31.9% | n/a | Energy | ||
ALMUN | €0.50 | 0% | -81.5% | €4.5m | €1.30 | PB0.4x | E150.0% | n/a | Tech | ||
ALCUR | €4.85 | -8.1% | 97.2% | €28.0m | €8.48 | PE15.5x | E42.4% | n/a | Capital Goods | ||
ALICA | €12.50 | 37.4% | -16.1% | €101.1m | €16.00 | PE18.4x | E26.1% | 1.6% | Tech | ||
MEDCL | €13.30 | -3.5% | 116.6% | €386.5m | €20.03 | PS32.4x | E72.7% | n/a | Pharmaceuticals & Biotech | ||
ALSMA | €3.71 | 0.8% | 35.4% | €19.3m | €5.80 | PE18.3x | E35.2% | n/a | Healthcare | ||
ALLIX | €9.01 | 8.8% | -12.2% | €58.6m | €16.00 | PS1.8x | E101.6% | n/a | Software | ||
S30 | €1.43 | -10.9% | -48.3% | €153.0m | €2.75 | PB1.4x | E102.6% | n/a | Software | ||
ALECP | €0.35 | -1.1% | -32.2% | €42.6m | n/a | PE47.3x | E86.8% | 0% | Media | ||
ALHOP | €20.90 | -6.7% | 12.1% | €60.0m | €30.05 | PE13.1x | E21.5% | 3.1% | Media | ||
ALCIS | €7.90 | -1.3% | -20.0% | €61.5m | €12.10 | PE19.3x | E56.2% | 2.1% | Commercial Services | ||
ATEME | €4.16 | -7.6% | -56.2% | €47.8m | €11.00 | PB1.3x | E91.5% | n/a | Tech | ||
OVH | €5.83 | 6.4% | -39.0% | €1.1b | €9.91 | PS1.2x | E101.5% | n/a | Software | ||
LSS | €27.55 | -3.0% | 0% | €1.0b | €35.70 | PE31.2x | E28.6% | 1.3% | Software | ||
ALLPL | €0.78 | -1.3% | -68.7% | €9.5m | €1.00 | PB6.7x | E97.3% | n/a | Consumer Services | ||
ALPAT | €13.90 | 10.3% | 5.3% | €15.3m | €11.50 | n/a | E92.7% | n/a | Pharmaceuticals & Biotech | ||
CLA | €1.71 | -5.4% | 3.9% | €97.1m | €4.75 | PE-19.4x | E90.6% | n/a | Software | ||
BLV | €14.70 | 2.1% | 29.4% | €1.5b | €15.84 | PS1.7x | E75.7% | n/a | Media |